Nora Tamara, Bouchonnet Francine, Labrosse Béatrice, Charpentier Charlotte, Mammano Fabrizio, Clavel François, Hance Allan J
Unité de Recherche Antivirale, INSERM U 552, Université Denis Diderot Paris 7, Paris F-75018, France.
Retrovirology. 2008 Feb 29;5:23. doi: 10.1186/1742-4690-5-23.
Numerous studies have shown that viral quasi-species with genetically diverse envelope proteins (Env) replicate simultaneously in patients infected with the human immunodeficiency virus type 1 (HIV-1). Less information is available concerning the extent that envelope sequence diversity translates into a diversity of phenotypic properties, including infectivity and resistance to entry inhibitors.
To study these questions, we isolated genetically distinct contemporaneous clonal viral populations from the plasma of 5 HIV-1 infected individuals (n = 70), and evaluated the infectivity of recombinant viruses expressing Env proteins from the clonal viruses in several target cells. The sensitivity to entry inhibitors (enfuvirtide, TAK-799), soluble CD4 and monoclonal antibodies (2G12, 48d, 2F5) was also evaluated for a subset of the recombinant viruses (n = 20).
Even when comparisons were restricted to viruses with similar tropism, the infectivity for a given target cell of viruses carrying different Env proteins from the same patient varied over an approximately 10-fold range, and differences in their relative ability to infect different target cells were also observed. Variable region haplotypes associated with high and low infectivity could be identified for one patient. In addition, clones carrying unique mutations in V3 often displayed low infectivity. No correlation was observed between viral infectivity and sensitivity to inhibition by any of the six entry inhibitors evaluated, indicating that these properties can be dissociated. Significant inter-patient differences, independent of infectivity, were observed for the sensitivity of Env proteins to several entry inhibitors and their ability to infect different target cells.
These findings demonstrate the marked functional heterogeneity of HIV-1 Env proteins expressed by contemporaneous circulating viruses, and underscore the advantage of clonal analyses in characterizing the spectrum of functional properties of the genetically diverse viral populations present in a given patient.
大量研究表明,具有基因多样化包膜蛋白(Env)的病毒准种在感染人类免疫缺陷病毒1型(HIV-1)的患者体内同时复制。关于包膜序列多样性转化为表型特性多样性(包括感染性和对进入抑制剂的抗性)的程度,目前所知较少。
为研究这些问题,我们从5名HIV-1感染个体的血浆中分离出基因不同的同期克隆病毒群体(n = 70),并评估了表达克隆病毒Env蛋白的重组病毒在几种靶细胞中的感染性。还对一部分重组病毒(n = 20)评估了其对进入抑制剂(恩夫韦肽、TAK-799)、可溶性CD4和单克隆抗体(2G12、48d、2F5)的敏感性。
即使将比较限于具有相似嗜性的病毒,来自同一患者携带不同Env蛋白的病毒对给定靶细胞的感染性在约10倍范围内变化,并且还观察到它们感染不同靶细胞的相对能力存在差异。对于一名患者,可以鉴定出与高感染性和低感染性相关的可变区单倍型。此外,在V3区携带独特突变的克隆通常表现出低感染性。在所评估的六种进入抑制剂中,未观察到病毒感染性与抑制敏感性之间的相关性,表明这些特性可以分离。在Env蛋白对几种进入抑制剂的敏感性及其感染不同靶细胞的能力方面,观察到了显著的患者间差异,且与感染性无关。
这些发现证明了同期循环病毒表达的HIV-1 Env蛋白具有明显的功能异质性,并强调了克隆分析在表征给定患者中存在的基因多样化病毒群体功能特性谱方面的优势。